z-logo
open-access-imgOpen Access
Endovascular Management of Central Retinal Arterial Occlusion
Author(s) -
Nitin Agarwal,
Nihar B. Gala,
Benjamin R. Baumrind,
David R. Hansberry,
Ahmad M. Thabet,
Chirag D. Gandhi,
Charles J. Prestigiacomo
Publication year - 2016
Publication title -
vascular and endovascular surgery/vascular and endovascular surgery
Language(s) - English
Resource type - Journals
eISSN - 1938-9116
pISSN - 1538-5744
DOI - 10.1177/1538574416682158
Subject(s) - medicine , central retinal artery occlusion , fibrinolysis , thrombolysis , surgery , paracentesis , retinal artery occlusion , conservative management , occlusion , ophthalmology , cardiology , visual acuity , myocardial infarction , retinal , ascites
Background and Importance: Central retinal artery occlusion (CRAO) is an ophthalmologic emergency due to the sudden cessation of circulation to the inner retinal layer. Without immediate treatment, permanent blindness may ensue. Several treatment options exist, ranging from noninvasive medical management to thrombolysis. Nonetheless, ongoing debate exists regarding the best therapeutic strategy.Case Presentation: The authors present the case of a 78-year-old woman with a medical history of hypercholesterolemia and rheumatoid arthritis who experienced complete loss of vision in her left eye. Following ophthalmologic evaluation demonstrating left CRAO, anterior chamber paracentesis was performed. Endovascular intervention was performed via local intra-arterial fibrinolysis with alteplase. Her vision returned to 20/20 following the procedure. In general, conventional therapies have not significantly improved patient outcomes.Conclusion: Several management options exist for CRAO. In general, conservative measures have not been reported to yield better patient outcomes as compared to the natural history of this medical emergency. Endovascular approaches are another option as observed with this case reported. In cases of CRAO, therapeutic strategies such as intra-arterial fibrinolysis utilize a local infusion of reactive tissue plasminogen activator directly at the site of occlusion via catheterization of the ophthalmic artery. Although several case series do show promising results after treating CRAO with intra-arterial fibrinolysis, further studies are required given the reports of complications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom